Cogent Biosciences Inc

NASDAQ:COGT   1:51:50 PM EDT
11.28
-0.12 (-1.05%)
Earnings Announcements

Cogent Biosciences Reports Recent Business Highlights

Published: 11/14/2022 13:24 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results.
Qtrly Net Loss per Share Attributable to Common Stockholders, Basic and Diluted $0.50.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.